MedTrace Inaugurates U.S. Headquarters in Downtown Minneapolis

MedTrace inaugurates U.S. headquarters in downtown Minneapolis Danish-born MedTrace is opening its new U.S. headquarters in Minneapolis’ IDS Center on September 7, 2022. The company expects to grow from 4 to 10 US-based employees within the next 12 months, and co-founder and COO Rune Wiik Kristensen will add “U.S. President” to his title when he […]

MedTrace Announces First Subject Scanned in Phase 3 Clinical Trial

MedTrace Pharma Announces First Subject Scanned in the Company’s RAPID-WATER-FLOW Phase 3 Clinical Trial First Subject Scanned in RAPID-WATER-FLOW Trial at Aarhus University Hospital, Denmark Multiple Sites Involved Across the United States, Denmark, Sweden, and The Netherlands The Global Trial is Expected to Continue for 12 Months MedTrace Pharma A/S, a pharma and device company […]

MedTrace Expands Management with Financial Strategist as CFO

MedTrace Expands Management and Appoints Financial Strategist Heavyweight as CFO Ann Kristin Led, former Exec. Vice President of Finance and Strategy at pharma company MC2 Therapeutics, is the new CFO at MedTrace from April 1. She will join CEO Martin Stenfeldt and COO Rune Wiik Kristensen as part of management and play a vital role […]

MedTrace Announces IND Approval of RAPID-WATER Phase 3 Clinical Trial

MedTrace Pharma Announces IND Approval with the Initiation of RAPID-WATER-FLOW Phase III Clinical Trial MedTrace Pharma A/S announced today the FDA approval of the company’s Investigational New Drug (IND) application and the approval to commence the RAPID-WATER-FLOW clinical trial to evaluate the use of 15O-water PET in diagnosing Coronary Artery Disease (CAD). The global trial […]

MedTrace Pharma Takes Step Towards CE Marking

MedTrace Pharma Takes Step Towards CE Marking A notified body has signed a contract to review MedTrace Pharma’s aQuant software and patient kit products with an eye to CE marking. The notified body, BSI, is based in the Netherlands. “We’re encouraged that BSI has agreed to audit our products,” says Rune Wiik Kristensen of MedTrace […]

MedTrace Installs P3 System at Sahlgrenska University Hospital

MedTrace Installs P3 System at Sahlgrenska University Hospital MedTrace Pharma A/S has signed a contract with Sahlgrenska University Hospital in Gothenburg, Sweden for the installation of a new P3 production and infusion system providing up to 1000 doses of 15O-water per year for the next five years. The Gothenburg-based hospital, one of the largest in […]

MedTrace Feature Article in Børsen

MedTrace Feature Article in Børsen MedTrace is proud to see a feature article in Børsen (May 26th, 2020), Denmarks leading business newspaper. CEO Martin Stenfeldt was interviewed about the latest progress, the next steps and his view on market launch estimates as well as exit opportunities. The article requires a subscription to Børsen to access […]

MedTrace Accomplishes Funding of DKK 21M

MedTrace Accomplishes Funding of DKK 21M <!– [if gte mso 9]> <![endif]–> <!– [if gte mso 9]> Normal 0 21 false false false EN-US X-NONE X-NONE <![endif]–><!– [if gte mso 9]> <![endif]–> MedTrace Pharma A/S has completed a capital raise against equity to advance our preparations for the upcoming clinical trial phase III. Three new […]

Putting the Low Radiation Dose of 15O-Water in Perspective

Putting the low radiation of 15O-water in perspective Tracers are radioactive compounds that doctors inject into patients to diagnose various diseases by, for example, following the flow of blood or use of sugar in organs. All tracers come with a radiation dose, but the dose of 15O-water is much lower than all other tracers used […]